28‐week, randomized, multicenter, open‐label, parallel‐group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice‐daily injections vs twice‐daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes

Aims/Introduction:  An insulin analogue formulation with a 7:3 ratio of rapid‐acting and intermediate‐acting fractions, biphasic insulin aspart 70 (BIAsp70) was developed to supplement basal insulin between meals and mimic the physiological pattern of postprandial insulin secretion. Materials and Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Takashi, Nishida, Tomoyuki, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008024/
https://www.ncbi.nlm.nih.gov/pubmed/24843416
http://dx.doi.org/10.1111/j.2040-1124.2010.00015.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008024/
https://www.ncbi.nlm.nih.gov/pubmed/24843416
http://dx.doi.org/10.1111/j.2040-1124.2010.00015.x

Ejemplares similares